Eastern Pulmonary Conference 2026 (EPC)

Palm Beach, FL US
September 10, 2026 to September 13, 2026

The Eastern Pulmonary Conference (EPC) is a CME meeting focused on clinical topics in Pulmonary Medicine. Through didactic lectures, panel discussions, and problem-based learning (PBL) case discussions, EPC combines the interactivity of a small regional conference with relevant information designed to improve diagnostic accuracy and treatment effectiveness for practitioners who care for patients with pulmonary diseases. Physicians, PAs, and NPs are invited to attend.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and the Eastern Pulmonary Conference (EPC). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 16.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 16.25 contact hours.

No commercial support was received for this activity.

Target Audience

Practicing allergists
Allied health professionals

Learning Objectives

At the conclusion of this activity learners should be able to…

  • Discuss the risks and benefits of treatment options for pulmonary fibrosis/ILD
  • Discuss the differential diagnosis and management of pulmonary hypertension 
  • Compare bronchodilator treatment options for asthma and COPD
  • Describe the clinical presentations, treatments, and outcomes in patients with NTM 
  • Discuss strategies for bronchoscopic ablation of lung cancer 
  • Appropriately prescribe biologic therapy for asthma management
  • Implement the newest guidelines in the management of asthma and COPD
  • Describe how identifying phenotypes of COPD can predict therapeutic responses
  • Implement recent advances in managing acute respiratory failure in the ICU
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months.

Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be ineligible companies. Examples of ineligible companies include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships with ineligible companies have been mitigated.

Course summary

Available credit: 
  • 16.25 AMA PRA Category 1 Credit™
  • 16.25 Attendance
  • 16.25 CBRN
Course opens: 
09/10/2026
Course expires: 
12/31/2026
Event starts: 
09/10/2026 - 2:30pm CDT
Event ends: 
09/13/2026 - 11:30am CDT
Add to calendar: 
Rating: 
0

Eastern Pulmonary Conference 2026
September 10-13, 2026
The Breakers | Palm Beach FL

All CME sessions will be held in Ponce 4

Thursday, September 10, 2026
Moderator: Reynold Panettieri, Jr, MD

4:00 - 4:30 pm

What's New in IPF

David Zisman, MD

3:30 - 4:00 pm

Lung Cancer: What's New

Gerard Silvestri, MD

4:30 - 4:40 pm

Panel Discussion: Q & A

 

4:40 - 5:50 pm

PBL: A 59-Year-Old Female with a Chronic Productive Cough

Don Bukstein, MD, Ray Davis, MD, Anas Hadeh, MD, Russell Settipane, MD

5:50 - 6:20 pm

Comparing the Guidelines for Adult Non-CF BE: ERS vs ACCP

Colin Swenson, MD

6:20 - 6:30 pm

Panel Discussion: Q & A

 

Friday, September 11, 2026
Moderator: Russell Settipane. MD

7:45 - 8:15 am

Pulmonary Hypertension Today

James Klinger, MD

8:15 - 8:45 am

When Vessels Go Awry: Secondary PAH in ILD

David Zisman, MD

8:45 - 8:55 am

Panel Discussion: Q & A

 

8:55 - 10:00 am           

 

PBL: A 68-Year-Old Male With Dyspnea on Exertion

Don Bukstein, MD, William Corrao, MD, Ray Davis, MD, Russell Settipane, MD

10:00 - 10:45 am
Ponce 5

Coffee Break - Visit Exhibits and Posters

 

10:45 - 11:15 am

Which Bronchodilator for Whom?

Reynold Panettieri, Jr, MD

11:15 - 11:45 am

What's Hot with a Shot? Biologics in COPD

Diego Maselli, MD

11:45 am - 12:15 pm

Cardiac or Not: Major CV Events in COPD

Nicola Hanania, MD

12:15 - 12:30 pm        

Panel Discussion: Q & A

 

Moderator: William Greisner III, MD

1:25 - 1:55 pm            

 

Updates in NTM Lung Disease Treatment

Colin Swenson, MD

1:55 - 2:25 pm           

 

Laryngeal Hypersensitivity and VCD/ILO - Clinical Spectrum of Upper Airway Masqueraders

Andrej Petrov, MD

 

2:25 - 2:50 pm               

 

Nasal Polyps in the Asthma Patient: Who Recurs and What Should the Pulmonologist Do?

Russell Settipane, MD

2:50 - 3:00 pm

Panel Discussion: Q & A

 

Saturday, September 12, 2026
Moderator: William Corrao, MD

7:45 - 8:15 am

Bronchoscopic Treatment of Peripheral Lung Tumors

Momen Wahidi, MD

8:15 - 8:45 am               

 

Is Surgery OK? Pre-op Evaluation to Prevent Post-op Complications in Patients with Lung Disease

Diego Maselli, MD

 

8:45-8:55 am

Panel Discussion: Q & A

 

8:55 - 10:00 am  

 

PBL: A 48-Year-Old Male With Severe Asthma and Persistent Dyspnea

Don Bukstein, MD, Ray Davis, MD, Russell Settipane, MD

 

10:00 - 10:45 am 
Ponce 5

Coffee Break - Visit Exhibits and Posters

 

10:45 - 11:15 am

Should We Unplug in Asthma and COPD?

Mario Castro, MD

11:15 - 11:45 am

When Steroids Don't Work: Low T2 Inflammation in Asthma

Monica Kraft, MD

11:45 am - 12:15 pm

Biologics in Asthma: Current and Future State

Njira Lugogo, MD

12:15 - 12:30 pm

Panel Discussion: Q & A

 

Moderator: William Greisner, III, MD

1:25 - 1:55 pm         

 

Time to Turn the Switch? Strategic Step-Downs in Severe Asthma

Nicola Hanania, MD

 

1:55 - 2:25 pm 

 

Is an Asthma Cure Possible, Plausible or Inevitable?

Mario Castro, MD

 

2:25 - 2:50 pm          

 

Assessment of Small Airways: What Have We Learned?

Monica Kraft, MD

 

2:50 - 3:00 pm            

Panel Discussion: Q & A

 

Sunday, September 13, 2026
Moderator: Reynold Panettieri, Jr, MD

8:15 - 8:45 am    

 

Real-World Data & How it Advances Our Understanding of Asthma Management in the Age of Biologics

Njira Lugogo, MD

8:45 - 9:15 am

Liberation from the Ventilator

Samantha Gillenwater, MD

9:15 - 9:45 am            

 

ECMO in the Lung Transplant Process

Juan Salgado, MD

9:45 - 10:15 am           

 

A Lot More Than Snoring: Sleep Disordered Breathing

Anas Hadeh, MD

 

10:15 - 10:30 am        

Panel Discussion: Q & A

 

The Breakers
One South County Road
Palm Beach, FL 33480
United States

All relevant financial relationships with ineligible companies have been mitigated.

Mario Castro, MD – Speaker
Consultant - Allakos, Amgen, Apogee, Apreo Health, Arrowhead Pharmaceuticals, AstraZeneca, Blueprint Medicines, Citrus Health, Connect BioPharma, Enveda, Evommune, Genentech, Generate:Biomedicines, GlaxoSmithKline, Genzyme, Jasper Therapeutics, Johnson & Johnson, Kinaset, Kymera, Novartis, Om Pharma, Pfizer, Pioneering Medicines, Polarean, Regeneron, Sanofi-Aventis, Teva, Uniquity Bio, Upstream Bio, Verona Pharmaceuticals
Researcher - Apogee Therapeutics, AstraZeneca, Celldex, Connect BioPharma, Enveda, Expedition Therapeutics, Gala Therapeutics, Genentech, GlaxoSmithKline, Kinaset Therapeutics, Kymera, Nocion, Novartis, Pfizer, Pulmatrix, Sanofi-Aventis, Shionogi, Teva, Regeneron
Speaker - Amgen, AstraZeneca, Regeneron, Sanofi-Aventis
Stocks - Aer Therapeutics

Ray Davis, MD – Facilitator
Consultant - Regeneron, Johnson and Johnson

Sandra Gawchik, DO – Moderator, Planner
Speaker - ARS

William Greisner III, MD – Moderator, Planner
Researcher - AstraZeneca, GSK, Regeneron, Teva

Anas Hadeh, MD – Planner, Moderator, Reviewer
Advisor - AstraZeneca, GSK, Insmed, Sanofi; Researcher - BI; Speaker - AstraZeneca, GSK, Insmed, Sanofi

Nicola Hanania, MD – Speaker 
Advisor/Consultant - Sanofi, Regeneron, AstraZeneca, Genentech, GSK, Connect Biopharma, Chiesi, Merck
Researcher - Sanofi, Regeneron, AstraZeneca, GSK, Chiesi, Merck, Genentech
Speaker - AstraZeneca, Sanofi

James Klinger, MD – Speaker
Independent Contractor - Pfizer, Merck, Tenex; Researcher - Gossamer, 35 Pharma

Monica Kraft, MD – Speaker
Researcher - GSK, Sanofi
Consultant - Chiesi, AstraZeneca, Sanofi, GSK, Uniquity Bio, Genentech, Abbvie, Kinaset
Speaker - Chiesi, AstraZeneca, Sanofi, GSK
Other - Co-Founder and CMO, RaeSedo, Inc.

Njira Lugogo, MD – Speaker
Advisor/Consultant - AbbVie, Amgen, Apogee, AstraZeneca, Avillion, Chiesi, Foresee, Genentech, GSK, Inctye, Johnson & Johnson, Niox, Novartis, Pfizer, Pharmosa, Regeneron, Sanofi, Teva
Speaker - GSK, Teva, Sanofi/Regeneron, AstraZeneca (non-speakers bureau)
Researcher - Amgen, AstraZeneca, Avillion, Bellus, Evidera, Gossamer Bio, Genentech, GSK, Janssen, Pfizer, Regeneron, Roche, Sanofi, Novartis, Teva

Diego Maselli, MD – Speaker
Advisor/Speaker - Amgen, AstraZeneca, GSK, Insmed, Sanofi/Regeneron

Reynold Panettieri, Jr, MD – Planner, Speaker
Advisor - AstraZeneca, GSK, Regeneron, Sanofi
Consultant - AstraZeneca, Sanofi
Research Grant - Medimmune, ConnectBio, Agomab, Genentech, Haleon
Researcher - AstraZeneca, GSK
Speaker - AstraZeneca, Regeneron, Sanofi

Gerard Silvestri, MD – Speaker
Consultant - Biodesix, Olympus
Researcher - Amgen, Adela, Biodesix, Olympus, Delfi Diagnostics, PrognomIQ, Exact Sciences Corp, Freenome Holdings, Nucleix, Qure.ai, Tempus
Speaker - Amgen

Russell Settipane, MD – Planner, Speaker, Moderator, Reviewer
Advisor - AstraZeneca, BioCryst, Celldex, Cogent, GSK, Novartis
Independent Contractor - AstraZeneca, BioCryst, GSK, Regeneron
Speaker - Amgen, ARS, AstraZeneca, Genentech, GSK, Grifols, Incyte, Novartis, Regeneron, Sanofi, Takeda

Colin Swenson, MD – Speaker
Advisor/Consultant - Boehringer Ingelheim, Insmed

Momen Wahidi, MD – Speaker
Consultant - Olympus, Cook Medical, BD, Verathon, Maverix Medical, Biodesix

David Zisman, MD – Speaker
Advisor - United Therapeutics, Liquidia, Boehringer Ingelheim, Pure-Tech
Consultant - United Therapeutics, Liquidia
Independent Contractor - Boehringer Ingelheim
Researcher - United Therapeutics, Liquidia
Speaker - United Therapeutics, Boehringer Ingelheim

The following have no relevant financial relationships with ineligible companies to disclose.
Joseph Bellanti, MD – Planner
Don Bukstein, MD – Speaker
William Corrao, MD – Planner, Moderator, Facilitator
Jill Courcier – Coordinator
Samantha Gillenwater, MD – Speaker
Katelyn Keedy, RN – Planner
Ginny Loiselle – Coordinator
Andrej Petrov, MD – Speaker
Juan Salgado, MD – Speaker
Robert Settipane, MD – Planner, Moderator, Reviewer

Available Credit

  • 16.25 AMA PRA Category 1 Credit™
  • 16.25 Attendance
  • 16.25 CBRN
Please login or create an account to take this course.